58 FINAL RESULTS – RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED SAFETY, ANTI-VIRAL PROOF-OF-CONCEPT STUDY OF MIRAVIRSEN, AN OLIGONUCLEOTIDE TARGETING MIR-122, IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HCV INFECTION

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2012-04, Vol.56, p.S26-S26
Main Authors: Reesink, H.W, Janssen, H.L.A, Zeuzem, S, Lawitz, E, Rodriguez-Torres, M, Patel, K, Chen, A, Davis, C, King, B, Levin, A, Hodges, M.R
Format: Article
Language:English
Subjects:
Gastroenterology and Hepatology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(12)60072-5